Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Havens

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The American Journal of Case Reports|June 5, 2020
Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-InfectionJoshua P Havens, Nichole N Regan, Sara H Bares
Plos One|May 23, 2023
Patient perspectives of antiretroviral pharmacy services: A cross-sectional cohort studyYadi Liu, Elizabeth Lyden, Renae Furl, et al.
Open Forum Infectious Diseases|November 2, 2020
Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure ProphylaxisShailendra V Selvaraj, Sara H Bares, Joshua P Havens
Journal of the American Pharmacists Association : Japha|February 15, 2021
Successful application of pharmacogenomic testing in the evaluation and management of a patient with human immunodeficiency virus and disseminated histoplasmosisKevin F Hanna, Joshua P Havens, Sara H Bares
Open Forum Infectious Diseases|September 17, 2020
Impact of Pharmacy Type on HIV Viral Suppression: A Retrospective Cross-Sectional Cohort StudyJoshua P Havens, Harlan Sayles, Nada Fadul, et al.
AIDS and Behavior|November 1, 2024
Doxycycline as Post-Exposure Prophylaxis: Awareness, Beliefs, and Interest Among Patients with and at Risk for HIVJoshua P Havens, Nathaniel Singh, Elizabeth Lyden, et al.
Open Forum Infectious Diseases|February 21, 2022
Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus ViremiaDarryl Sokpa, Elizabeth Lyden, Nada Fadul, et al.
Open Forum Infectious Diseases|January 10, 2025
Week 96 Results of Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in People With Substance Use DisordersJoshua P Havens, Sara H Bares, Elizabeth Lyden, et al.
AIDS Patient Care and Stds|June 2, 2025
HIV and Ongoing Methamphetamine Use: A Grounded Theory of Engagement in HIV Care from the BASE StudyLiam Heerten-Rodriguez, Jason D Coleman, Sofia Jawed-Wessel, et al.
Clinical Pharmacokinetics|November 4, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated ReviewJoshua P Havens, Anthony T Podany, Kimberly K Scarsi, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The American Journal of Case Reports|June 5, 2020
Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-InfectionJoshua P Havens, Nichole N Regan, Sara H Bares
Plos One|May 23, 2023
Patient perspectives of antiretroviral pharmacy services: A cross-sectional cohort studyYadi Liu, Elizabeth Lyden, Renae Furl, et al.
Open Forum Infectious Diseases|November 2, 2020
Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure ProphylaxisShailendra V Selvaraj, Sara H Bares, Joshua P Havens
Journal of the American Pharmacists Association : Japha|February 15, 2021
Successful application of pharmacogenomic testing in the evaluation and management of a patient with human immunodeficiency virus and disseminated histoplasmosisKevin F Hanna, Joshua P Havens, Sara H Bares
Open Forum Infectious Diseases|September 17, 2020
Impact of Pharmacy Type on HIV Viral Suppression: A Retrospective Cross-Sectional Cohort StudyJoshua P Havens, Harlan Sayles, Nada Fadul, et al.
AIDS and Behavior|November 1, 2024
Doxycycline as Post-Exposure Prophylaxis: Awareness, Beliefs, and Interest Among Patients with and at Risk for HIVJoshua P Havens, Nathaniel Singh, Elizabeth Lyden, et al.
Open Forum Infectious Diseases|February 21, 2022
Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus ViremiaDarryl Sokpa, Elizabeth Lyden, Nada Fadul, et al.
Open Forum Infectious Diseases|January 10, 2025
Week 96 Results of Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in People With Substance Use DisordersJoshua P Havens, Sara H Bares, Elizabeth Lyden, et al.
AIDS Patient Care and Stds|June 2, 2025
HIV and Ongoing Methamphetamine Use: A Grounded Theory of Engagement in HIV Care from the BASE StudyLiam Heerten-Rodriguez, Jason D Coleman, Sofia Jawed-Wessel, et al.
Clinical Pharmacokinetics|November 4, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated ReviewJoshua P Havens, Anthony T Podany, Kimberly K Scarsi, et al.
Pageof 3